319 related articles for article (PubMed ID: 28414239)
1. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies.
Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR
Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239
[TBL] [Abstract][Full Text] [Related]
2. Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment.
Chen IH; Xiao H; Daly T; Li N
Anal Chem; 2020 Mar; 92(5):3751-3757. PubMed ID: 31999105
[TBL] [Abstract][Full Text] [Related]
3. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner.
Chen IH; Xiao H; Li N
Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367
[TBL] [Abstract][Full Text] [Related]
4. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis.
Madsen JA; Farutin V; Carbeau T; Wudyka S; Yin Y; Smith S; Anderson J; Capila I
MAbs; 2015; 7(6):1128-37. PubMed ID: 26291024
[TBL] [Abstract][Full Text] [Related]
5. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development.
Huang Y; Molden R; Hu M; Qiu H; Li N
J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758
[TBL] [Abstract][Full Text] [Related]
6. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry.
Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J
MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446
[TBL] [Abstract][Full Text] [Related]
7. Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data with Parallel Reaction Monitoring Verification.
Kreimer S; Gao Y; Ray S; Jin M; Tan Z; Mussa NA; Tao L; Li Z; Ivanov AR; Karger BL
Anal Chem; 2017 May; 89(10):5294-5302. PubMed ID: 28402653
[TBL] [Abstract][Full Text] [Related]
8. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.
Doneanu CE; Xenopoulos A; Fadgen K; Murphy J; Skilton SJ; Prentice H; Stapels M; Chen W
MAbs; 2012; 4(1):24-44. PubMed ID: 22327428
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Detection of Low-Abundance Host Cell Protein Impurities in High-Purity Monoclonal Antibodies Down to 1 ppm Using Ion Mobility Mass Spectrometry Coupled with Multidimensional Liquid Chromatography.
Doneanu CE; Anderson M; Williams BJ; Lauber MA; Chakraborty A; Chen W
Anal Chem; 2015 Oct; 87(20):10283-91. PubMed ID: 26266576
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric evaluation of upstream and downstream process influences on host cell protein patterns in biopharmaceutical products.
Falkenberg H; Waldera-Lupa DM; Vanderlaan M; Schwab T; Krapfenbauer K; Studts JM; Flad T; Waerner T
Biotechnol Prog; 2019 May; 35(3):e2788. PubMed ID: 30767403
[TBL] [Abstract][Full Text] [Related]
12. Ultrasensitive method for profiling host cell proteins by coupling limited digestion to ProteoMiner technology.
Zhang S; Xiao H; Li N
Anal Biochem; 2022 Nov; 657():114901. PubMed ID: 36130653
[TBL] [Abstract][Full Text] [Related]
13. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry.
Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR
Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048
[TBL] [Abstract][Full Text] [Related]
14. Improved detection of host cell proteins (HCPs) in a mammalian cell-derived antibody drug using liquid chromatography/mass spectrometry in conjunction with an HCP-enrichment strategy.
Thompson JH; Chung WK; Zhu M; Tie L; Lu Y; Aboulaich N; Strouse R; Mo WD
Rapid Commun Mass Spectrom; 2014 Apr; 28(8):855-60. PubMed ID: 24623688
[TBL] [Abstract][Full Text] [Related]
15. Versatile LC-MS-Based Workflow with Robust 0.1 ppm Sensitivity for Identifying Residual HCPs in Biotherapeutic Products.
Yang F; Li D; Kufer R; Cadang L; Zhang J; Dai L; Guo J; Wohlrab S; Greenwood-Goodwin M; Shen A; Duan D; Li H; Yuk IH
Anal Chem; 2022 Jan; 94(2):723-731. PubMed ID: 34927411
[TBL] [Abstract][Full Text] [Related]
16. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
Goey CH; Bell D; Kontoravdi C
MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
[TBL] [Abstract][Full Text] [Related]
17. Identification of a host cell protein impurity in therapeutic protein, P1.
Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G
J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935
[TBL] [Abstract][Full Text] [Related]
18. Quantitative host cell protein analysis using two dimensional data independent LC-MS(E).
Farrell A; Mittermayr S; Morrissey B; Mc Loughlin N; Navas Iglesias N; Marison IW; Bones J
Anal Chem; 2015 Sep; 87(18):9186-93. PubMed ID: 26280711
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Host-Cell Protein Detection in Protein Therapeutics Using HILIC Enrichment and Proteomic Analysis.
Wang Q; Slaney TR; Wu W; Ludwig R; Tao L; Leone A
Anal Chem; 2020 Aug; 92(15):10327-10335. PubMed ID: 32614163
[TBL] [Abstract][Full Text] [Related]
20. Host cell protein detection gap risk mitigation: quantitative IAC-MS for ELISA antibody reagent coverage determination.
Waldera-Lupa DM; Jasper Y; Köhne P; Schwichtenhövel R; Falkenberg H; Flad T; Happersberger P; Reisinger B; Dehghani A; Moussa R; Waerner T
MAbs; 2021; 13(1):1955432. PubMed ID: 34347561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]